Hepatitis D A012
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/h-l/hepatitis-d-a012-b160b161b170b180
Rulebase for hepatitis D
<h5><strong>Current RMA Instruments</strong></h5><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2017/011.pdf" target="_blank">Reasonable Hypothesis SOP</a></address></td><td>11 of 2017</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2017/012.pdf" target="_blank">Balance of Probabilities SOP </a></address></td><td>12 of 2017</td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="27e2a4bc-9845-4aaf-b789-fcf746c778c8" data-view-mode="wysiwyg"></drupal-media></p><h5> ICD Coding</h5><ul><li>ICD-9-CM Codes: <span> </span>070.42, 070.52</li><li>ICD-10-AM Codes: B17.0</li></ul><h5>Brief description</h5><p>Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.</p><h5>Confirming the diagnosis</h5><p>The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.</p><p>The relevant medical specialist is a gastroenterologist or hepatologist. </p><h5>Additional diagnoses covered by SOP</h5><ul><li>Delta virus infection</li></ul><h5>Conditions not covered by SOP</h5><ul><li>Hepatitis A*</li><li>Hepatitis B*</li><li>Hepatitis C*</li><li>Hepatitis E*</li></ul><p>* Another SOP applies</p><h5>Clinical onset</h5><p>Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).</p><p>Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.</p><h5>Clinical worsening</h5><p>The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.</p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d
An injection with an unsterilised needle
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/injection-unsterilised-needle
Blood transfusion
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/blood-transfusion
Contamination of a wound by the bodily fluids of another person
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/contamination-wound-bodily-fluids-another-person
Dental procedure with unsterilised instruments
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/dental-procedure-unsterilised-instruments
Inability to obtain appropriate clinical management for hepatitis D
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/inability-obtain-appropriate-clinical-management-hepatitis-d
Injection of blood products
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/injection-blood-products
Organ transplant
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/organ-transplant
Parenteral drug use
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/parenteral-drug-use
Surgical procedure with unsterilised instruments
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/surgical-procedure-unsterilised-instruments
Unprotected sexual intercourse
Current RMA Instruments
| Reasonable Hypothesis SOP | 11 of 2017 |
| Balance of Probabilities SOP | 12 of 2017 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 070.42, 070.52
- ICD-10-AM Codes: B17.0
Brief description
Hepatitis D is a viral infection of the liver. The infection requires and always occurs in conjunction with Hepatitis B virus (HBV) infection. Onset may be at the same time as that of the HBV (co-infection) or occur later (superinfection). Persistence of Hepatitis D virus (HDV) infection is dependent upon persistence of HBV infection.
Confirming the diagnosis
The diagnosis of Hepatitis D requires: confirmation of the presence of Hepatitis B infection, usually from serology positive for HBsAg; and, the presence of Hepatitis D virus antibodies (anti-HDV) or Hepatitis D virus ribonucleic acid (HDV RNA) on laboratory testing.
The relevant medical specialist is a gastroenterologist or hepatologist.
Additional diagnoses covered by SOP
- Delta virus infection
Conditions not covered by SOP
- Hepatitis A*
- Hepatitis B*
- Hepatitis C*
- Hepatitis E*
* Another SOP applies
Clinical onset
Acute Hepatitis B + D co-infection is clinically indistinguishable from Hepatitis B virus infection alone. Clinical onset of co-infection will be at the time of onset of HBV infection. Evidence of acute HBV infection (see CLIK SOP information for Hepatits B) and contemporary positive laboratory evidence of HDV infection will be required to confirm co-infection (note: anti-HDV antibody is usually detectable after approxiamtely four weeks of acute infection with Hepatitis D).
Superinfection with Hepatitis D may manifest as a severe acute hepatitis in a previously unrecognized HBV carrier, or as an exacerbation of preexisting chronic Hepatitis B. Clinical onset can be based on the timing of clinical manifestations, once HDV infection has been confirmed. Documented anti-HDV seroconversion (from negative to positive) may be the only practical way to confirm the timing of acute HDV superinfection.
Clinical worsening
The natural course of the condition ranges from resolution (if HBV infection resolves), though asymptomatic carrier state, to fulminant liver failure. There is no current specific treatment for Hepatitis D infection.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-d-a012-b160b161b170b180/rulebase-hepatitis-d/unprotected-sexual-intercourse